Trexquant Investment LP Paratek Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.94 - $4.77 $174,871 - $283,719	-59,480 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.07 - $5.3 $108,314 - $141,048	26,613 Added 80.97%	59,480 $267,000
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $154,474 - $237,957	32,867 New	32,867 $160,000
Q1 2021 May 13, 2021	SELL	$6.14 - $8.31 $188,995 - $255,790	-30,781 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$4.58 - $7.14 $140,976 - $219,776	30,781 New	30,781 $193,000
Q3 2018 Nov 09, 2018	SELL	$9.05 - $10.95 $220,240 - $266,479	-24,336 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$10.2 - $13.9 $166,943 - $227,501	-16,367 Reduced 40.21%	24,336 $248,000
Q1 2018 May 03, 2018	BUY	$12.65 - $18.85 $514,892 - $767,251	40,703 New	40,703 $529,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.